000950SZSE

Announcement of Abnormal Stock Trading Fluctuations

C.Q. Pharmaceutical Holding Co., Ltd.·April 6, 2026·2 pages

✨ AI Summary

This announcement addresses the abnormal trading fluctuations of Chongqing Pharmaceutical Holdings Co., Ltd. stock, which exceeded a 20% price deviation over two consecutive trading days. The company confirms that there are no undisclosed significant matters affecting stock prices and that operations remain normal. The board assures compliance with disclosure regulations and will release the 2025 annual report on April 24, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement of Abnormal Stock Trading Fluctuations

Securities Code: 000950
Securities Abbreviation: Chongqing Pharmaceutical Holdings
Announcement Number: 2026-019

I. Introduction to Abnormal Stock Trading Fluctuations

Chongqing Pharmaceutical Holdings Co., Ltd. (hereinafter referred to as "the Company") stock (abbreviation: Chongqing Pharmaceutical Holdings, code: 000950) experienced a cumulative price increase deviation exceeding 20% over two consecutive trading days on April 2 and April 3, 2026. This situation is classified as abnormal trading fluctuations according to the relevant provisions of the Shenzhen Stock Exchange Trading Rules.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.